BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21321342)

  • 1. Tumefactive demyelination, an uncommon form of tacrolimus neurotoxicity.
    Kim SH; Kim W; Lee KW; Hong EK; Kim HJ
    Neurology; 2011 Feb; 76(7):672-4. PubMed ID: 21321342
    [No Abstract]   [Full Text] [Related]  

  • 2. Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity.
    Venneti S; Moss HE; Levin MH; Vagefi MR; Brozena SC; Pruitt AA; Mourelatos Z; Trojanowski JQ; Galetta SL; Balcer LJ
    J Neurol Sci; 2011 Feb; 301(1-2):112-5. PubMed ID: 21112060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus-induced polyneuropathy after heart transplantation.
    Labate A; Morelli M; Palamara G; Pirritano D; Quattrone A
    Clin Neuropharmacol; 2010 May; 33(3):161-2. PubMed ID: 20502136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catatonia as a manifestation of tacrolimus-induced neurotoxicity in organ transplant patients: a case series.
    Chopra A; Das P; Rai A; Kuppuswamy PS; Li X; Huston J; Philbrick K; Sola C
    Gen Hosp Psychiatry; 2012; 34(2):209.e9-11. PubMed ID: 21937118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic demyelinating polyneuropathy secondary to treatment with tacrolimus].
    Rodríguez-Gómez D; Rodríguez-Rodríguez A; Pérez-Carral O; Lustres-Pérez M; Cid-Rodríguez MC
    Rev Neurol; 2008 Feb 1-15; 46(3):189-90. PubMed ID: 18297634
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation.
    Wu Q; Marescaux C; Wolff V; Jeung MY; Kessler R; Lauer V; Chen Y
    Eur Neurol; 2010; 64(3):169-77. PubMed ID: 20699617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pearls & Oy-sters: Tacrolimus neurotoxicity presenting as an isolated brainstem lesion.
    Saadi A; Schmahmann JD
    Neurology; 2016 Mar; 86(11):e109-11. PubMed ID: 26976521
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute peripheral demyelinating polyneuropathy and acute renal failure after administration of FK506].
    Laham G; Vilches A; Jost L; Jost L; Nogués M
    Medicina (B Aires); 2001; 61(4):445-6. PubMed ID: 11563175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506).
    Small SL; Fukui MB; Bramblett GT; Eidelman BH
    Ann Neurol; 1996 Oct; 40(4):575-80. PubMed ID: 8871576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumefactive demyelination of the spinal cord.
    Yaghi S; Gokdin M; Sethi H
    Acta Neurol Belg; 2010 Jun; 110(2):206-8. PubMed ID: 20873455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Posterior reversible encephalopathy secondary to tacrolimus].
    Marinas Alejo A; Gutiérrez-Gutiérrez G; Carrera Goñil N
    Neurologia; 2005 Sep; 20(7):379. PubMed ID: 16163584
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible tacrolimus-induced neurotoxicity isolated to the brain stem.
    Oliverio PJ; Restrepo L; Mitchell SA; Tornatore CS; Frankel SR
    AJNR Am J Neuroradiol; 2000 Aug; 21(7):1251-4. PubMed ID: 10954277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus neurotoxicity and the role of the Renin-Angiotensin system.
    Hategan A; Bourgeois JA
    J Neuropsychiatry Clin Neurosci; 2015; 27(2):e140-1. PubMed ID: 25923858
    [No Abstract]   [Full Text] [Related]  

  • 14. Akinetic mutism induced by tacrolimus.
    Sierra-Hidalgo F; Martínez-Salio A; Moreno-García S; de Pablo-Fernández E; Correas-Callero E; Ruiz-Morales J
    Clin Neuropharmacol; 2009; 32(5):293-4. PubMed ID: 19820432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demyelinization and occipital atrophy due to cyclosporin A].
    Landete Pascual L; Valero Merino C; Casanova Estruch B
    Neurologia; 1999 Nov; 14(9):459. PubMed ID: 10613020
    [No Abstract]   [Full Text] [Related]  

  • 16. Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis.
    Zhang Y; Metz LM
    Neurology; 2010 Oct; 75(15):1396. PubMed ID: 20938034
    [No Abstract]   [Full Text] [Related]  

  • 17. Gout in liver transplant patients receiving tacrolimus.
    Gerster JC; Dudler M; Halkic N; Gillet M
    Ann Rheum Dis; 2004 Jul; 63(7):894-5. PubMed ID: 15194597
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent tumefactive demyelination in a child.
    Puri V; Chaudhry N; Gulati P; Tatke M; Singh D
    J Clin Neurosci; 2005 May; 12(4):495-500. PubMed ID: 15925795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation.
    Frühauf NR; Koeppen Dagger S; Saner FH; Egelhof Dagger T; Stavrou G; Nadalin S; Broelsch CE
    Liver Transpl; 2003 Sep; 9(9):983-5. PubMed ID: 12942462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.